Ningbo Tianyi Medical Appliance Co., Ltd. (SHE:301097)
China · Delayed Price · Currency is CNY 33.20
-1.38 (-3.99%)
At close: Aug 24, 2026
SHE:301097 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 2,603 | 2,969 | 2,105 | 3,102 | 3,329 | - | |
Market Cap Growth | -0.28% | 41.04% | -32.14% | -6.82% | - | - |
Enterprise Value | 2,931 | 2,941 | 1,744 | 2,580 | 2,517 | - |
Last Close Price | 33.20 | 36.50 | 25.53 | 36.26 | 38.50 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 48.80 | 38.89 | - |
Forward PE | - | 25.59 | - | - | - | - |
PS Ratio | 3.79 | 5.16 | 5.03 | 8.14 | 8.34 | - |
PB Ratio | 2.56 | 2.59 | 1.77 | 2.42 | 2.70 | - |
P/TBV Ratio | 3.28 | 3.24 | 1.94 | 2.59 | 2.88 | - |
P/OCF Ratio | 48.58 | 31.21 | 35.77 | 42.71 | 66.35 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 4.27 | 5.11 | 4.16 | 6.77 | 6.30 | - |
EV/EBITDA Ratio | 21.63 | 33.20 | 99.11 | 39.05 | 29.13 | - |
EV/EBIT Ratio | 46.32 | 87.75 | - | 81.72 | 43.65 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.91 | 0.58 | 0.33 | 0.28 | 0.23 | 0.49 |
Debt / EBITDA Ratio | 6.84 | 7.48 | 22.29 | 5.38 | 3.26 | 1.88 |
Debt / FCF Ratio | - | - | - | - | - | 3.45 |
Net Debt / Equity Ratio | 0.32 | 0.06 | -0.29 | -0.43 | -0.59 | -0.26 |
Net Debt / EBITDA Ratio | 2.44 | 0.79 | -19.67 | -8.31 | -8.51 | -0.99 |
Net Debt / FCF Ratio | -0.94 | -0.33 | 7.19 | 3.70 | 7.43 | -1.81 |
Asset Turnover | 0.34 | 0.30 | 0.24 | 0.22 | 0.33 | 0.56 |
Inventory Turnover | 3.03 | 3.28 | 3.21 | 3.21 | 5.18 | 6.06 |
Quick Ratio | 1.01 | 1.35 | 2.22 | 3.14 | 3.23 | 1.18 |
Current Ratio | 1.33 | 1.64 | 2.55 | 3.52 | 3.45 | 1.33 |
Return on Equity (ROE) | -0.95% | -1.39% | -0.50% | 4.78% | 10.00% | 18.20% |
Return on Assets (ROA) | 1.94% | 1.08% | -0.90% | 1.16% | 2.96% | 8.31% |
Return on Invested Capital (ROIC) | 4.76% | 3.25% | -3.25% | 4.26% | 11.70% | 25.59% |
Return on Capital Employed (ROCE) | 4.30% | 2.20% | -1.80% | 2.20% | 4.50% | 20.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -0.37% | -0.55% | -0.03% | 2.05% | 2.57% | - |
FCF Yield | -13.36% | -7.09% | -2.29% | -4.79% | -2.97% | - |
Dividend Yield | 1.01% | 0.98% | 1.40% | 0.99% | 0.93% | - |
Payout Ratio | - | - | - | 61.54% | 25.52% | 8.84% |
Buyback Yield / Dilution | 18.84% | 22.56% | -27.12% | -6.59% | -24.92% | 0.06% |
Total Shareholder Return | 19.85% | 23.54% | -25.72% | -5.60% | -23.99% | 0.06% |